This paper investigates the epidemiology and public health response of novel coronavirus infection (COVID-19) in the Nordic region. The data on cases and deaths due to COVID-19 were drawn from the European Centre for Disease Prevention and Control. The data on age- and sex-wise cases, deaths and intensive care unit (ICU) admissions, and public health interventions in the Nordic region through November 10, 2020, were obtained from respective countries’ health ministries. Sweden accounted for 60.59% of cases (162 240 of 267 768 cases) and 81% of deaths (6057 of 7477 cases) in the Nordic region. The incidence rate for the Nordic region was 989.59 per 100 000, varying from 327.30 per 100 000 in Finland to 1616.51 per 100 000 in Sweden, and the mortality rate for the region was 27.63 per 100 000, ranging from 5.3 per 100 000 in Norway to 60.35 per 100 000 in Sweden. The case–fatality ratio of the Nordic region was 2.79%. Females were more susceptible to COVID-19 infection than males (52.30% vs 47.66%), while males had a greater proportion of deaths (54.7%) and ICU need (71.99%) than females. It is imperative to continue with social distancing, mandatory masks, testing, prohibition of mass gatherings, isolation of confirmed cases, and preventing the importation of cases from other countries to avoid the further resurgence of cases.
LuHStrattonCWTangYW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi:10.1002/jmv.25678
World Health Organization Coronavirus Disease (COVID-19) Dashboard. Accessed November 10, 2020. https://covid19.who.int/
5.
AhnDGShinHJKimMH, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3):313–324. doi:10.4014/jmb.2003.03011
United Nation, Department of Economics and Social Affairs Population Dynamics. World population prospects 2019. Accessed June 9, 2020. https://population.un.org/wpp/
Directorate of Health and Department of Civil Protection and Emergency Management. COVID-19 in Iceland. Accessed November 11, 2020. https://www.covid.is/data
15.
WHO Regional Office for Europe, European Commission, and European Observatory on Health Systems and Policies. COVID-19 health system response monitor. Accessed November 11, 2020. https://www.covid19healthsystem.org/mainpage.aspx
GémesKTalbäckMModigK, et al. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden. Eur J Epidemiol. 2020;35:401–409. doi:10.1007/s10654-020-00646-z
21.
ContiPYounesA. Coronavirus COV-19/SARS-CoV-2 affects women less than men: Clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):71.
22.
DaviesNGKlepacPLiuY, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med.2020;26(8):1205–1211. doi:10.1038/s41591-020-0962-9
FuruseYSandoETsuchiyaN, et al. Clusters of coronavirus disease in communities, Japan, January–April 2020. Emerg Infect Dis. 2020;26(9):2176–2179. doi:10.3201/eid2609.202272
25.
BonanadCGarcía-BlasSTarazona-SantabalbinaF, et al. The effect of age on mortality in patients with Covid-19: A metanalysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21:915–918.
26.
DrefahlSWallaceMMussinoE, et al. A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nat Commun. 2020;11(1):1–7. doi:10.1038/s41467-020-18926-3
27.
OksanenAKaakinenMLatikkaR, et al. Regulation and trust: 3-month follow-up study on COVID-19 mortality in 25 European countries. JMIR Public Health Surveill. 2020;6(2):e19218. doi:10.2196/19218
28.
OlagnierDMogensenTH. The Covid-19 pandemic in Denmark: Big lessons from a small country. Cytokine Growth Factor Rev. 2020;53:10–12.
29.
SjödinHJohanssonAFBrännströmÅ, et al. COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios. Int J Epidemiol. 2020;49(5):1443–1453. doi:10.1093/ije/dyaa121
30.
ChristensenTLægreidP. Balancing governance capacity and legitimacy—How the Norwegian government handled the COVID-19 crisis as a high performer. Public Adm Rev. 2020;80(5):774–779. doi:10.1111/puar.13241
31.
TiirinkiHTynkkynenLKSovalaM, et al. COVID-19 pandemic in Finland—preliminary analysis on health system response and economic consequences. Health Policy Technol. 2020;9(4):649–662. doi:10.1016/j.hlpt.2020.08.005
SmithACThomasESnoswellCL, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;26(5):309–313. doi:10.1177/1357633X20916567
37.
HanETanMMJTurkE, et al. Lessons learnt from easing COVID-19 restrictions: An analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–1534. doi:10.1016/S0140-6736(20)32007-9
38.
KamerlinSCKassonPM. Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control. Clin Infect Dis. 2020;71(12):3174–3181. doi:10.1093/cid/ciaa864
39.
FlaxmanSMishraSGandyA, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–261. doi:10.1038/s41586-020-2405-7
BakerMGWilsonNAnglemyerA. Successful elimination of Covid-19 transmission in New Zealand. N Engl J Med. 2020;383(8):e56.
44.
LeeVJChiewCJKhongWX. Interrupting transmission of COVID-19: Lessons from containment efforts in Singapore. J Travel Med. 2020;27(3):taaa039. doi:10.1093/jtm/taaa039
45.
WangCJNgCYBrookRH. Response to COVID-19 in Taiwan: Big data analytics, new technology, and proactive testing. JAMA. 2020;323(14):1341–1342. doi:10.1001/jama.2020.3151
